Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insufficiency. Crit Care Clin 2001; 17: 25–41.
Beishuizen A, Thijs LG. Relative adrenal failure in intensive care: an identifiable problem requiring treatment? Best Pract Res Clin Endocrinol Metab 2001; 15: 513–531.
Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med 2003; 348: 727–734.
Dimopoulou I, Tsagarakis S, Kouyialis AT, et al. Hypothalamicpituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med 2004; 32: 404–408.
Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36: 1937–1949.
Marik PE. Critical illness related corticosteroid insufficiency. Chest 2009; 135: 181–193.
Sibbald W, Short A, Cohen M, et al. Variations in adrenocortical responsiveness during severe bacterial infections. Ann Surg 1977; 186: 29–33.
Moran J, Chapman M, O'Fathartaigh M, et al. Hypercortisolemia and adrenocortical responsiveness at onset of septic shock. Intensive Care Med 1994; 20: 489–495.
Soni A, Pepper GM, Wyrwinski PM, et al. Adrenal insufficiency occurring during septic shock—incidence, outcome, and relationship to peripheral cytokine levels. Am J Med 1995; 98: 266–271.
Rivers EP, Gaspari M, Saad GA, et al. Adrenal insufficiency in high-risk surgical ICU patients. Chest 2001; 119: 889–896.
Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–871.
Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006; 2006: 1319–1326.
Bollart PE, Charpentier C, Levy B, et al. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645–650.
Soliman AT, Taman KH, Rizk MM, et al. Circulating adrenocorticotropic hormone (ACTH) and cortisol concentrations in normal, appropriate-for-gestational-age newborns versus those with sepsis and respiratory distress: cortisol response to low-dose and standard-dose ACTH tests. Metabolism 2004; 53: 209–214.
Annane D. Glucocorticoids in the treatment of severe sepsis and septic shock. Curr Opin Crit Care 2005; 11: 449–453.
McKee JI, Finlay WEI. Cortisol replacement in severely stressed patients. Lancet 1983; 1:484.
Burkitt JM, Haskins SC, Nelson RW, et al. Relative adrenal insufficiency in dogs with sepsis. J Vet Intern Med 2007; 21: 226–231.
Martin LG, Groman RP, Fletcher DJ, et al. Pituitary-adrenal function in dogs with acute critical illness. J Am Vet Med Assoc 2008; 233: 87–95.
Couëtil LL, Hoffman AM. Adrenal insufficiency in a neonatal foal. JAm Vet Med Assoc 1998; 212: 1594–1596.
Durkan S, de Laforcade A, Rozanski E, et al. Suspected relative adrenal insufficiency in a critically ill cat. J Vet Emerg Crit Care 2007; 17: 197–201.
Peyton JL, Burkitt JM. Critical illness-related corticosteroid insufficiency in a dog with septic shock. J Vet Emerg Crit Care 2009; 19: 262–268.
Rossdale PD, Silver M, Ellis L, et al. Response of the adrenal cortex to tetracosactrin (ACTH1–24) in the premature and full term foal. J Reprod Fert Suppl 1982; 32: 545–553.
Gold JR, Divers TJ, Barton MH, et al. Plasma adrenocorticotropin, cortisol, and adrenocorticotropin/cortisol ratios in septic and normal-term foals. J Vet Intern Med 2007; 21: 791–796.
Hurcombe SDA, Toribio RE, Slovis N, et al. Blood arginine vasopressin, adrenocorticotropin hormone, and cortisol concentrations at admission in septic and critically ill foals and their association with survival. J Vet Intern Med 2008; 22: 639–647.
Wong DM, Vo DT, Alcott CJ, et al. Baseline plasma cortisol and ACTH concentrations and response to low-dose ACTH stimulation testing in ill foals. J Am Vet Med Assoc 2009; 234: 126–132.
Hart KA, Slovis NM, Barton MH. Hypothalamic-pituitary-adrenal axis dysfunction in hospitalized neonatal foals. J Vet Intern Med 2009; 23: 901–912.
Hinchcliff KW, Rush BR, Farris JW. Evaluation of plasma catecholamine and serum cortisol concentrations in horses with colic. J Am Vet Med Assoc 2005; 227: 276–280.
Capen CC. Endocrine glands. In: Maxie MG, ed. Jubb, Kennedy, and Palmer's pathology of domestic animals. Vol 3. 5th ed. Edinburgh, Saunders Elsevier, 2007;410.
Annane D, Sebille V, Troche G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038–1045.
Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill—a new look at an old problem. Chest 2002; 122: 1784–1796.
Kozyra EF, Wax RS, Burry LD. Can 1 microg of cosyntropin be used to evaluate adrenal insufficiency in critically ill patients? Ann Pharmacother 2005; 39: 691–698.
Oelkers W. Adrenal insufficiency. N Engl J Med 1996; 335: 1206–1212.
Beishuizen A, van Lijf JH, Lekkerkerker JFF, et al. The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Neth J Med 2000; 56: 91–99.
Gonc EN, Kandemir N, Kinik ST. Significance of low-dose and standard-dose ACTH tests compared to overnight metyrapone test in the diagnosis of adrenal insufficiency in childhood. Horm Res 2003; 60: 191–197.
Eiler H, Goble D, Oliver J. Adrenal gland function in the horse: effects of cosyntropin (synthetic) and corticotropin (natural) stimulation. Am J Vet Res 1979; 40: 724–726.
Golland LC, Evans DL, Stone GM, et al. Plasma cortisol and beta-endorphin concentrations in trained and over-trained Standardbred racehorses. Pflugers Arch 1999; 439: 11–17.
Bousquet-Melou A, Formentini E, Picard-Hagen N, et al. The adrenocorticotropin stimulation test: contribution of a physiologically based model developed in horse for its interpretation in different pathophysiological situations encountered in man. Endocrinology 2006; 147: 4281–4291.
Marc M, Parvizi N, Ellendorff F, et al. Plasma cortisol and ACTH concentrations in the Warmblood horse in response to a standardized treadmill exercise test as physiological markers for evaluation of training status. J Anim Sci 2000; 78: 1936–1946.
Golland LC, Evans DL, Stone GM, et al. The effect of overtraining on plasma cortisol concentrations at rest and in response to exercise and administration of synthetic adrenocorticotropin in Standardbred racehorses. Pferdeheilkunde 1996; 12: 531–533.
Dickstein G, Shechner C, Nicholson WE, et al. Adrenocorticotropin stimulation test: effects of basal Cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab 1991; 72: 773–778.
Kemppainen R, Clark T, Peterson M. Preservative effect of aprotinin on canine plasma immunoreactive adrenocorticotropin concentrations. Domest Anim Endocrinol 1994; 11: 353–362.
Ralston JM, Stenhouse AM, Stenhouse NS, et al. Cortisol concentrations in blood and urine of horses. Aust Vet J 1988; 65: 1–5.
Dowling PM, Williams MA, Clark TP. Adrenal insufficiency associated with long-term anabolic steroid administration in a horse. J Am Vet Med Assoc 1993; 203: 1166–1169.
Dybdal NO, Hargreaves KM, Madigan JE, et al. Diagnostic testing for pituitary pars intermedia dysfunction in horses. J Am Vet Med Assoc 1994; 204: 627–632.
Caloni F, Spotti M, Villa R, et al. Hydrocortisone levels in the urine and blood of horses treated with ACTH. Equine Vet J 1999; 31: 273–276.
Hart KA, Ferguson DC, Heusner GL, et al. Synthetic adrenocorticotropic hormone stimulation tests in healthy neonatal foals. J Vet Intern Med 2007; 21: 314–321.
Martin LG, Behrend EN, Mealey KL, et al. Effect of low doses of cosyntropin on serum Cortisol concentrations in clinically normal dogs. Am J Vet Res 2007; 68: 555–560.
Frank LA, Oliver JW. Comparison of serum Cortisol concentrations in clinically normal dogs after administration of freshly reconstituted versus reconstituted and stored frozen cosyntropin. J Am Vet Med Assoc 1998; 212: 1569–1571.
Couetil L, Paradis MR, Knoll J. Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. J Vet Intern Med 1996; 10: 1–6.
Donaldson MT, McDonnell SM, Schanbacher BJ, et al. Variation in plasma adrenocorticotropic hormone concentration and dexamethasone suppression test results with season, age, and sex in healthy ponies and horses. J Vet Intern Med 2005; 19: 217–222.
Advertisement
Objective—To determine the lowest ACTH dose that would induce a maximum increase in serum cortisol concentration in healthy adult horses and identify the time to peak cortisol concentration.
Design—Evaluation study.
Animals—8 healthy adult horses.
Procedures—Saline (0.9% NaCl) solution or 1 of 4 doses (0.02, 0.1, 0.25, and 0.5 μg/kg [0.009, 0.045, 0.114, and 0.227 μg/lb]) of cosyntropin (synthetic ACTH) were administered IV (5 treatments/horse). Serum cortisol concentrations were measured before and 30, 60, 90, 120, 180, and 240 minutes after injection of cosyntropin or saline solution; CBCs were performed before and 30, 60, 120, and 240 minutes after injection.
Results—For all 4 doses, serum cortisol concentration was significantly increased, compared with the baseline value, by 30 minutes after administration of cosyntropin; no significant differences were detected among maximum serum cortisol concentrations obtained in response to administration of doses of 0.1, 0.25, and 0.5 μg/kg. Serum cortisol concentration peaked 30 minutes after administration of cosyntropin at a dose of 0.02 or 0.1 μg/kg, with peak concentrations 1.5 and 1.9 times, respectively, the baseline concentration. Serum cortisol concentration peaked 90 minutes after administration of cosyntropin at a dose of 0.25 or 0.5 μg/kg, with peak concentrations 2.0 and 2.3 times, respectively, the baseline concentration. Cosyntropin administration significantly affected WBC, neutrophil, and eosinophil counts and the neutrophil-to-lymphocyte ratio.
Conclusions and Clinical Relevance—Results suggested that in healthy horses, administration of cosyntropin at a dose of 0.1 μg/kg resulted in maximum adrenal stimulation, with peak cortisol concentration 30 minutes after cosyntropin administration.
Supported by the Birmingham Racing Commission.
Presented in abstract form at the 9th World Equine Veterinary Association Congress, Marrakesh, Morocco, January 2006, and at the Auburn University College of Veterinary Medicine Phi Zeta Research Day, Auburn, Ala, November 2006.
The authors thank Chanda Moxam, Tony Wolfe, Christopher Schreiber, Nicholas Smith, and Heather Smith for technical assistance.